Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

WHEATON® Highlights Products at AACC 2014

Published: Thursday, July 24, 2014
Last Updated: Thursday, July 24, 2014
Bookmark and Share
The products to be featured at the meeting offer unique solutions for the clinical market.

WHEATON® today highlighted products to be featured at the 2014 AACC Annual Meeting that provide unique solutions addressing the specific needs of clinical laboratory and other clinical life sciences customers. These products showcase the company’s ongoing commitment to provide a range of distinctive products that provide solutions to the growing clinical testing sector.
 
WHEATON’S CryoElite Tissue Vials are designed for the safe, secure and effective cryopreservation of biological tissue specimens, which are essential for advances in biomedical research and have demanding requirements for cryogenic storage. They provide researchers a uniform vial able to maintain sample integrity while maximizing storage capacity and organization. CryoElite Tissue Vials were developed with input from industry thought leaders for the high performance tissue banking requirements of anatomical pathology departments, clinical trial organizations and biorepository and biobanking facilities. They offer researchers and clinicians who work with biological specimens ease of use, convenience and security for their precious samples.
 
MicroLiter Chromatography Vials are the industry’s most versatile and innovative, designed for high precision, trouble-free operation for both GC and HPLC applications. All MircroLiter Vials are Class 10,000 clean room packed, making them the clear choice for challenging clinical LOD and LOQ assays and limited quantity specimens and unknown targets.   A complete range of size and closure types are available, designed to the tightest tolerances to ensure that they exceed all autosampler specifications.  When high throughput applications require the use of glass vials, the MicroLiter MPSS allows for robotic liquid handling with the patented “uLmat” that eliminates leakage and cross contamination between wells.
 
Our line of High Recovery Vials has a unique patented interior bottom design, allowing for maximum retrieval of contents and enabling more tests to be conducted from a single vial, providing greater resource efficiency for in vitro diagnostics and diagnostic kits. They are designed for manual or automated handling and storage, and are especially useful for high value reagents and samples, reducing product waste by 99% and enabling full product retrieval without the need to overfill.
 
“We are investing substantial resources to better understand the specific needs of the clinical lab customer and create product solutions addressing those needs, by incorporating innovative, value-added features that help them do their jobs more effectively and efficiently,” said Wayne L. Brinster, CEO and President of WHEATON. “Our CryoElite Tissue Vials provide crucial performance advantages to the rapidly growing tissue banking field; our High Recovery Vials offer much-needed efficiencies to users of high value reagents; and our high precision, versatile, easy to use MicroLiter Chromatography Vials and other WHEATON specialty products show how our 125-year commitment to ongoing innovation and excellence help bring the benefits of scientific advances to our customers and all those they serve.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Wayne Brinster Joins WHEATON® as President
The company will continue its focus on supporting laboratory research, and packaging for diagnostics and specialty pharmaceutical markets.
Friday, October 26, 2012
Scientific News
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Imaging Software Could Speed Breast Cancer Diagnosis
Technology could improve access to diagnostic services in developing countries.
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Data Mining DNA For Polycystic Ovary Syndrome Genes
A new Northwestern Medicine genome-wide association study of PCOS – the first of its kind to focus on women of European ancestry – has provided important new insights into the underlying biology of the disorder.
Algorithm Interprets Breathing Difficulties to Aid in Medical Care
Researchers from North Carolina State University have developed an efficient algorithm that can interpret the wheezing of patients with breathing difficulties to give medical providers information about what’s happening in the lungs.
Researchers Develop qPCR Prognosis Test for NSCLC Patients
A nine-gene molecular prognostic index (MPI) for patients with early-stage non-small cell lung cancer (NSCLC) was able to provide accurate survival stratification and could potentially inform the use of adjuvant therapy in patients struggling with the disease.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!